Gabapentin
Product Images NDC 45865-356

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 45865-356). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Pdp (356 60)

Pdp (356 60)
Gabapentin Tablets 600mg is a generic medication for Neurontin. Each tablet contains 500mg of Gabapentin. It is suggested to avoid alcohol consumption while taking the medicine as it may cause dizziness or drowsiness. The prescription requires taking a certain number of tablets multiple times a day. The description includes information about the manufacturer, NDC, and lot number.*
FDA Label Image

Equate (Equation)

Equate (Equation)
This text seems to be a medical formula for estimating kidney function based on age, weight, and serum creatinine levels. It may be useful for doctors or medical professionals in diagnosing or treating kidney-related conditions.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
The text describes a table with columns representing different treatment options (placebo, gabapentin 1800mg/day, gabapentin 2400mg/day) and rows representing the pain score at baseline, and after 1 and 4 weeks of treatment. The text does not provide any further context or information.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
The text represents a graph showing the proportion of patients who experienced a reduction in pain score in controlled studies of PHN (post-herpetic neuralgia) after being treated with a certain medication. The graph shows percentages ranging from 0% to 100%, in increments of 10%. The studies are labeled Study 1 and Study 2, and two medications are shown: PBO and GBP (possibly gabapentin). The numbers next to the medication labels (PBO GBP 3500 PBO GBP 1800 GBP 2400) are not clear and may be dosages or other data points. The asterisks indicate statistical significance. Therefore, the text provides information regarding the efficacy of different medication treatments for PHN in controlled clinical studies.*
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
FDA Label Image

Molecule (Molecule)

Molecule (Molecule)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.